EA033027B1 - Ослабленные вакцины от свиного гриппа и способы их получения и применения - Google Patents

Ослабленные вакцины от свиного гриппа и способы их получения и применения

Info

Publication number
EA033027B1
EA033027B1 EA201500140A EA201500140A EA033027B1 EA 033027 B1 EA033027 B1 EA 033027B1 EA 201500140 A EA201500140 A EA 201500140A EA 201500140 A EA201500140 A EA 201500140A EA 033027 B1 EA033027 B1 EA 033027B1
Authority
EA
Eurasian Patent Office
Prior art keywords
attenuated
methods
influenza
making
strains
Prior art date
Application number
EA201500140A
Other languages
English (en)
Other versions
EA201500140A1 (ru
Inventor
Бенджамин М. Хаус
Original Assignee
Мериал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мериал, Инк. filed Critical Мериал, Инк.
Publication of EA201500140A1 publication Critical patent/EA201500140A1/ru
Publication of EA033027B1 publication Critical patent/EA033027B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Представлены ослабленные штаммы вируса свиного гриппа, в частности те, что получены методами обратной генетики, содержащие их композиции и способы их получения и применения. Ослабленные штаммы подвергались инженерии с тем, чтобы они кодировали белки НА, содержащие дополнительные сайты гликозилирования по сравнению с белками НА, кодируемыми соответствующими исходными вирулентными вирусами. Предпочтительно ослабленные штаммы вируса гриппа вводятся свиньям для выработки у них эффективного иммунитета против гриппа или заболеваний, вызванных вирусом гриппа.
EA201500140A 2012-07-17 2013-07-11 Ослабленные вакцины от свиного гриппа и способы их получения и применения EA033027B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261672398P 2012-07-17 2012-07-17
PCT/US2013/050000 WO2014014726A1 (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof

Publications (2)

Publication Number Publication Date
EA201500140A1 EA201500140A1 (ru) 2016-02-29
EA033027B1 true EA033027B1 (ru) 2019-08-30

Family

ID=48874529

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500140A EA033027B1 (ru) 2012-07-17 2013-07-11 Ослабленные вакцины от свиного гриппа и способы их получения и применения

Country Status (20)

Country Link
US (2) US9216211B2 (ru)
EP (1) EP2874656B1 (ru)
JP (1) JP6467672B2 (ru)
KR (1) KR102027758B1 (ru)
CN (1) CN104582725B (ru)
AU (2) AU2013290597B2 (ru)
BR (1) BR112015001020B1 (ru)
CA (1) CA2879228C (ru)
DK (1) DK2874656T3 (ru)
EA (1) EA033027B1 (ru)
ES (1) ES2662022T3 (ru)
HK (1) HK1209325A1 (ru)
HU (1) HUE036110T2 (ru)
MX (1) MX365880B (ru)
MY (1) MY166879A (ru)
NZ (2) NZ704188A (ru)
PH (1) PH12015500095B1 (ru)
PL (1) PL2874656T3 (ru)
PT (1) PT2874656T (ru)
WO (1) WO2014014726A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE036110T2 (hu) * 2012-07-17 2018-06-28 Merial Inc Legyengített sertésinfluenza vakcinák és eljárások azok elõállítására és alkalmazására
AU2016380864B2 (en) * 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
EP3548078A1 (en) * 2016-11-30 2019-10-09 Boehringer Ingelheim Animal Health USA Inc. Attenuated swine influenza vaccines and methods of making and use thereof
CN106939355A (zh) * 2017-03-01 2017-07-11 苏州系统医学研究所 一种流感病毒弱毒活疫苗毒株的筛选和鉴定方法
CN107064499B (zh) * 2017-03-15 2019-06-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091376A2 (en) * 2010-01-24 2011-07-28 Biological Mimetics, Inc. Immunogenic influenza composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US5585250A (en) 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
JP2006525815A (ja) 2003-05-28 2006-11-16 ウィスコンシン・アラムナイ・リサーチ・ファウンデイション Ｐｏｌｉｉプロモーターおよびリボザイムを有する組換えインフルエンザベクター
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
US8673613B2 (en) * 2007-06-18 2014-03-18 Medimmune, Llc Influenza B viruses having alterations in the hemaglutinin polypeptide
CN102014953A (zh) 2008-02-21 2011-04-13 生物模仿公司 流感免疫原组合物
HUE036110T2 (hu) * 2012-07-17 2018-06-28 Merial Inc Legyengített sertésinfluenza vakcinák és eljárások azok elõállítására és alkalmazására

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091376A2 (en) * 2010-01-24 2011-07-28 Biological Mimetics, Inc. Immunogenic influenza composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ABE Y, TAKASHITA E, SUGAWARA K, MATSUZAKI Y, MURAKI Y, HONGO S.: "Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.", JOURNAL OF VIROLOGY., THE AMERICAN SOCIETY FOR MICROBIOLOGY., US, vol. 78, no. 18, 1 September 2004 (2004-09-01), US, pages 9605 - 9611, XP002717640, ISSN: 0022-538X, DOI: 10.1128/JVI.78.18.9605-9611.2004 *
VINCENT, A.L. MA, W. LAGER, K.M. JANKE, B.H. WEBBY, R.J. GARCIA-SASTRE, A. RICHT, J.A.: "Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 47, 26 October 2007 (2007-10-26), AMSTERDAM, NL, pages 7999 - 8009, XP022317477, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2007.09.019 *

Also Published As

Publication number Publication date
MX2015000713A (es) 2015-10-12
CA2879228A1 (en) 2014-01-23
CA2879228C (en) 2021-07-13
AU2013290597A1 (en) 2015-02-19
BR112015001020B1 (pt) 2022-04-19
EP2874656A1 (en) 2015-05-27
KR20150036685A (ko) 2015-04-07
HUE036110T2 (hu) 2018-06-28
PT2874656T (pt) 2018-03-09
EA201500140A1 (ru) 2016-02-29
HK1209325A1 (en) 2016-04-01
CN104582725A (zh) 2015-04-29
US9216211B2 (en) 2015-12-22
CN104582725B (zh) 2017-06-23
AU2016202693A1 (en) 2016-05-19
US20160120973A1 (en) 2016-05-05
BR112015001020A2 (ru) 2017-08-15
NZ704188A (en) 2016-04-29
NZ712713A (en) 2017-05-26
MY166879A (en) 2018-07-24
PH12015500095A1 (en) 2015-03-02
AU2016202693B2 (en) 2017-11-16
JP6467672B2 (ja) 2019-02-13
US9623105B2 (en) 2017-04-18
DK2874656T3 (en) 2018-01-15
EP2874656B1 (en) 2017-12-06
PH12015500095B1 (en) 2015-03-02
JP2015524266A (ja) 2015-08-24
WO2014014726A1 (en) 2014-01-23
MX365880B (es) 2019-06-18
US20140023681A1 (en) 2014-01-23
ES2662022T3 (es) 2018-04-05
KR102027758B1 (ko) 2019-10-02
PL2874656T3 (pl) 2018-04-30
AU2013290597B2 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
MX2016003419A (es) Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
MX2020011717A (es) Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas.
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
MD3718565T2 (ro) Vaccinuri împotriva virusului respirator
PH12017500727A1 (en) Modified virus-like particles of cmv
NZ630869A (en) Compositions and methods for dengue virus chimeric constructs in vaccines
MX2014003308A (es) Vacunas para el virus de la influenza y usos de las mismas.
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
MX2021010060A (es) Produccion de virus en huevos aviares.
BR112015008417A2 (pt) composição imunogênica, e, vacina
PH12015000376A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
EA033027B1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
MX2017016896A (es) Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
MX2013003245A (es) Vacuna contra virus de diarrea viral de bovinos.
CL2012003219A1 (es) Parapoxvirus recombinante que comprende un parapoxvirus y adn heterólogo derivado de un virus de la rabia; procedimiento de preparación de dicho parapoxvirus; composicion inmunogénica; uso de la composicion para inducir respuesta inmunitaria contra el virus de la rabia en un animal.
DK201370530A (en) Salmonid alphavirus vaccine
MX2015014005A (es) Complejo inmunogenico para vacunacion y metodo de obtencion.
IN2015DN02772A (ru)
MX2018001251A (es) Respuesta inmunitaria potenciada de las especies porcinas.
GB2515222A (en) Use of flagellin as a vaccine
MX350718B (es) Vacuna de rinitis equina.
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
MX2014009022A (es) Virus de influenza c y vacuna.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM